[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin,2018,68(6):394-424.
[2] Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res,2018,30(1):1-12.
[3] Wang Z, Chen M, Pan J, et al. Pattern of distant metastases in inflammatory breast cancer - A large-cohort retrospective study. J Cancer,2020,11(2):292-300.
[4] Santosh B, Varshney A, Yadava P K. Non-coding RNAs: biological functions and applications. Cell Biochem Funct,2015,33(1):14-22.
[5] Ren X. Genome-wide analysis reveals the emerging roles of long non-coding RNAs in cancer. Oncol Lett,2020,19(1):588-594.
[6] Huang Y, Guo Q, Ding X P, et al. Mechanism of long noncoding RNAs as transcriptional regulators in cancer. RNA Biol,2019.
[7] Zhang K, Liu P, Tang H, et al. AFAP1-AS1 promotes epithelial-mesenchymal transition and tumorigenesis through Wnt/β-catenin signaling pathway in triple-negative breast cancer. Frontiers in Pharmacology,2018,9(NOV).
[8] Yang F, Shen Y, Zhang W, et al. An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer. Cell death and differentiation,2018.
[9] Wang P, Chou C, Lin C, et al. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer. ONCOGENE,2018,37(34):4662-4678.
[10] Sha S, Yuan D, Liu Y, et al. Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression. BIOLOGY OPEN,2017,6(9):1310-1316.
[11] Shima H, Kida K, Adachi S, et al. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness. Breast Cancer Research and Treatment,2018,170(3):507-516.
[12] Li S, Zhou J, Wang Z, et al. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. BIOMEDICINE & PHARMACOTHERAPY,2018,104:451-457.
[13] Zuo Y, Li Y, Zhou Z, et al. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer. BIOMEDICINE & PHARMACOTHERAPY,2017,95:922-928.
[14] Li L, Yang Z, Wang Y, et al. Long non-coding RNA MALAT1 promote triple-negative breast cancer progression by regulating miR-204 expression. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,2016,9(2):969.
[15] Sun Z, Zhang T, Chen B. Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b. Med Sci Monit,2019,25:1410-1422.
[16] Liu Y, Wei G, Ma Q, et al. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis. Thorac Cancer,2020.
[17] Niu Y, Bao L, Chen Y, et al. HIF-2-induced long non-coding RNA RAB11B-AS1 promotes hypoxia-mediated angiogenesis and breast cancer metastasis. Cancer Res,2020.
[18] Cui Y, Lu C, Zhang Z, et al. A Long Non-coding RNA Lnc712 Regulates Breast Cancer Cell Proliferation. Int J Biol Sci,2020,16(1):162-171.
[19] Naorem L D, Prakash V S, Muthaiyan M, et al. Comprehensive analysis of dysregulated lncRNAs and their competing endogenous RNA network in triple-negative breast cancer. Int J Biol Macromol,2019.
[20] Zhao J, Jiao Y, Song Y, et al. Stanniocalcin 2 Ameliorates Hepatosteatosis Through Activation of STAT3 Signaling. Front Physiol,2018,9:873.
[21] Joshi A D, Hossain E, Elferink C J. Epigenetic Regulation by Agonist-Specific Aryl Hydrocarbon Receptor Recruitment of Metastasis-Associated Protein 2 Selectively Induces Stanniocalcin 2 Expression. Mol Pharmacol,2017,92(3):366-374.
[22] Roche F P, Pietila I, Kaito H, et al. Leukocyte Differentiation by Histidine-Rich Glycoprotein/Stanniocalcin-2 Complex Regulates Murine Glioma Growth through Modulation of Antitumor Immunity. Mol Cancer Ther,2018,17(9):1961-1972.
[23] Li J B, Liu Z X, Zhang R, et al. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma. World J Gastroenterol,2019,25(22):2776-2787.
[24] He H, Qie S, Guo Q, et al. Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells. Cancer Manag Res,2019,11:6411-6424.
[25] Aydin H A, Toptas T, Bozkurt S, et al. Stanniocalcin-2 May Be a Potentially Valuable Prognostic Marker in Endometrial Cancer: a Preliminary Study. Pathol Oncol Res,2019,25(2):751-757.
[26] Ke J, Zhang B H, Li Y Y, et al. MiR-1-3p suppresses cell proliferation and invasion and targets STC2 in gastric cancer. Eur Rev Med Pharmacol Sci,2019,23(20):8870-8877.
[27] Wang Y, Wu J, Xu J, et al. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma. Biosci Rep,2019,39(4).
[28] Li T, Qin Y, Zhen Z, et al. Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma. Cell Prolif,2019,52(5):e12651.
[29] Zakaria N, Yahaya B H. Adipose-Derived Mesenchymal Stem Cells Promote Growth and Migration of Lung Adenocarcinoma Cancer Cells. Adv Exp Med Biol,2020.
[30] Tripathi S, Levine H, Jolly M K. The Physics of Cellular Decision Making During Epithelial-Mesenchymal Transition. Annu Rev Biophys,2020.
[31] Xue K, Li J, Nan S, et al. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206. Life Sci,2019,231:116459.
[32] Sun G, Liu M, Han H. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer. J Cell Physiol,2019,234(10):17824-17838.
[33] Xue K, Li J, Nan S, et al. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206. Life Sci,2019,231:116459.